Dashboard
Manage Tickers

LMAT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wells-fargo-maintains-equal-weight-on-lemaitre-vascular-lowers-price-target-to-93
Wells Fargo Maintains Equal-Weight on LeMa...
11/07/2025 18:55:37

Wells Fargo analyst Nathan Treybeck maintains LeMaitre Vascular (NASDAQ:LMAT) with a Equal-Weight and lowers the price targe...

lemaitre-vascular-raises-fy2025-gaap-eps-guidance-from-223-237-to-248-253-vs-227-est-lowers-fy2025-sales-guidance-from-248000m-254000m-to-247000m-249000m-vs-250617m-est
LeMaitre Vascular Raises FY2025 GAAP EPS G...
11/06/2025 21:07:58

LeMaitre Vascular (NASDAQ:LMAT) raises FY2025 GAAP EPS guidance from $2.23-$2.37 to $2.48-$2.53 vs $2.27 analyst estimate. Lowe...

lemaitre-vascular-sees-q4-gaap-eps-064-069-vs-063-est-sees-sales-61800m-63800m-vs-64324m-est
LeMaitre Vascular Sees Q4 GAAP EPS $0.64-$...
11/06/2025 21:07:29

LeMaitre Vascular (NASDAQ:LMAT) is looking for Q4 GAAP EPS of $0.64-$0.69 vs $0.63 analyst estimate. sees sales of $61.800 mill...

lemaitre-vascular-q3-eps-075-beats-057-estimate-sales-61046m-miss-62181m-estimate
LeMaitre Vascular Q3 EPS $0.75 Beats $0.57...
11/06/2025 21:05:46

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.75 per share which beat the analyst consensus estimate of $0....

earnings-scheduled-for-november-6-2025
Earnings Scheduled For November 6, 2025
11/06/2025 11:12:19

roth-capital-reinstates-buy-on-lemaitre-vascular-announces-108-price-target
Roth Capital Reinstates Buy on LeMaitre Va...
11/05/2025 17:29:34

Roth Capital analyst Kyle Bauser reinstates LeMaitre Vascular (NASDAQ:LMAT) with a Buy and announces $108 price target.

where-lemaitre-vascular-stands-with-analysts
Where LeMaitre Vascular Stands With Analysts
10/15/2025 12:00:51

barrington-research-maintains-outperform-on-lemaitre-vascular-maintains-95-price-target
Barrington Research Maintains Outperform o...
10/15/2025 11:49:11

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 pr...

barrington-research-maintains-outperform-on-lemaitre-vascular-maintains-95-price-target
Barrington Research Maintains Outperform o...
09/23/2025 15:15:36

Barrington Research analyst Michael Petusky maintains LeMaitre Vascular (NASDAQ:LMAT) with a Outperform and maintains $95 pr...

cantor-fitzgerald-maintains-neutral-on-lemaitre-vascular-raises-price-target-to-95
Cantor Fitzgerald Maintains Neutral on LeM...
08/06/2025 14:03:06

Cantor Fitzgerald analyst Ross Osborn maintains LeMaitre Vascular (NASDAQ:LMAT) with a Neutral and raises the price target f...

barrington-research-upgrades-lemaitre-vascular-to-outperform-announces-95-price-target
Barrington Research Upgrades LeMaitre Vasc...
08/06/2025 13:06:36

Barrington Research analyst Michael Petusky upgrades LeMaitre Vascular (NASDAQ:LMAT) from Market Perform to Outperform and a...

lemaitre-vascular-sees-q3-gaap-eps-054-059-vs-054-est-sees-sales-61200m-63200m-vs-60923m-est
LeMaitre Vascular Sees Q3 GAAP EPS $0.54-$...
08/05/2025 20:23:31

LeMaitre Vascular (NASDAQ:LMAT) is looking for Q3 GAAP EPS of $0.54-$0.59 vs $0.54 analyst estimate. sees sales of $61.200 mill...

lemaitre-vascular-raises-fy2025-gaap-eps-guidance-from-207-224-to-223-237-vs-215-est-raises-fy2025-sales-guidance-from-242000m-249000m-to-248000m-254000m-vs-245469m-est
LeMaitre Vascular Raises FY2025 GAAP EPS G...
08/05/2025 20:23:19

LeMaitre Vascular (NASDAQ:LMAT) raises FY2025 GAAP EPS guidance from $2.07-$2.24 to $2.23-$2.37 vs $2.15 analyst estimate. Rais...

lemaitre-vascular-q2-eps-060-beats-057-estimate-sales-64232m-beat-62480m-estimate
LeMaitre Vascular Q2 EPS $0.60 Beats $0.57...
08/05/2025 20:08:22

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0....

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

barrington-research-reiterates-market-perform-on-lemaitre-vascularto-market-perform
Barrington Research Reiterates Market Perf...
07/22/2025 14:27:30

Barrington Research analyst Michael Petusky reiterates LeMaitre Vascular (NASDAQ:LMAT) from Market Perform to Market Perform.

lemaitre-vascular-lowers-fy2025-gaap-eps-guidance-from-215-232-to-207-224-vs-224-est-raises-fy2025-sales-guidance-from-23540m-24280m-to-24200m-24900m-vs-23926m-est
LeMaitre Vascular Lowers FY2025 GAAP EPS G...
05/01/2025 20:14:05

LeMaitre Vascular (NASDAQ:LMAT) lowers FY2025 GAAP EPS guidance from $2.15-$2.32 to $2.07-$2.24 vs $2.24 analyst estimate. Rais...

lemaitre-vascular-sees-q2-gaap-eps-055-059-vs-058-est-sees-sales-61500m-63500m-vs-6087m-est
LeMaitre Vascular Sees Q2 GAAP EPS $0.55-$...
05/01/2025 20:13:56

LeMaitre Vascular (NASDAQ:LMAT) is looking for Q2 GAAP EPS of $0.55-$0.59 vs $0.58 analyst estimate. sees sales of $61.500 mill...

lemaitre-vascular-q1-eps-048-misses-050-estimate-sales-5987m-beat-5764m-estimate
LeMaitre Vascular Q1 EPS $0.48 Misses $0.5...
05/01/2025 20:08:04

LeMaitre Vascular (NASDAQ:LMAT) reported quarterly earnings of $0.48 per share which missed the analyst consensus estimate of $...

Core News & Articles
Earnings Scheduled For May 1, 2025
05/01/2025 08:32:37

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION